Company Filing History:
Years Active: 2017
Title: Michael Durben: Innovator in Bispecific Antibody Technology
Introduction
Michael Durben is a prominent inventor based in Tuebingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibody molecules. His innovative work has the potential to advance therapeutic strategies in immunology.
Latest Patents
Michael Durben holds 1 patent for a bispecific antibody molecule. This invention relates to a bispecific antibody molecule, along with a method for producing it, its use, and a nucleic acid molecule encoding the bispecific antibody molecule. The invention specifically provides an antibody molecule capable of mediating target cell-restricted activation of immune cells.
Career Highlights
Michael Durben is associated with Synimmune GmbH, a company focused on developing innovative immunotherapies. His work at Synimmune has positioned him as a key player in the biotechnology sector, contributing to advancements in antibody technology.
Collaborations
Some of his notable coworkers include Gundram Jung and Ludger Grosse-Hovest. Their collaborative efforts have further enhanced the research and development initiatives at Synimmune GmbH.
Conclusion
Michael Durben's contributions to bispecific antibody technology exemplify the innovative spirit of modern biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.